Type I interferons: diversity of sources, production pathways and effects on immune responses
- PMID: 22440910
- PMCID: PMC3572907
- DOI: 10.1016/j.coviro.2011.10.026
Type I interferons: diversity of sources, production pathways and effects on immune responses
Abstract
Type I interferons (IFN-I) were first described over 50 years ago as factors produced by cells that interfere with virus replication and promote an antiviral state. Innate and adaptive immune responses to viruses are also greatly influenced by IFN-I. In this article we discuss the diversity of cellular sources of IFN-I and the pathways leading to IFN-I production during viral infections. Finally, we discuss the effects of IFN-I on cells of the immune system with emphasis on dendritic cells.
Copyright © 2011 Elsevier B.V. All rights reserved.
Figures
Similar articles
-
Cytosolic surveillance and antiviral immunity.Curr Opin Virol. 2011 Dec;1(6):455-62. doi: 10.1016/j.coviro.2011.11.004. Epub 2011 Dec 4. Curr Opin Virol. 2011. PMID: 22440909 Free PMC article. Review.
-
Balancing viral replication in spleen and liver determines the outcome of systemic virus infection.Z Gastroenterol. 2015 Dec;53(12):1432-5. doi: 10.1055/s-0041-109631. Epub 2015 Dec 14. Z Gastroenterol. 2015. PMID: 26666281 Review.
-
Innate immune response to viral infection.Cytokine. 2008 Sep;43(3):336-41. doi: 10.1016/j.cyto.2008.07.009. Epub 2008 Aug 9. Cytokine. 2008. PMID: 18694646 Review.
-
Innate barriers to viral infection.Future Microbiol. 2012 Jul;7(7):815-22. doi: 10.2217/fmb.12.52. Future Microbiol. 2012. PMID: 22827304
-
Exposing viruses: RNA patterns sensed by RIG-I-like receptors.J Clin Immunol. 2010 Jul;30(4):491-5. doi: 10.1007/s10875-010-9384-7. Epub 2010 Mar 31. J Clin Immunol. 2010. PMID: 20354786 Review.
Cited by
-
Evasion of interferon-mediated immune response by arteriviruses.Front Immunol. 2022 Aug 15;13:963923. doi: 10.3389/fimmu.2022.963923. eCollection 2022. Front Immunol. 2022. PMID: 36091073 Free PMC article. Review.
-
Role of CCL2/CCR2 axis in the pathogenesis of COVID-19 and possible Treatments: All options on the Table.Int Immunopharmacol. 2022 Dec;113(Pt A):109325. doi: 10.1016/j.intimp.2022.109325. Epub 2022 Oct 14. Int Immunopharmacol. 2022. PMID: 36252475 Free PMC article. Review.
-
The type-I interferon response potentiates seeded tau aggregation and exacerbates tau pathology.Alzheimers Dement. 2024 Feb;20(2):1013-1025. doi: 10.1002/alz.13493. Epub 2023 Oct 17. Alzheimers Dement. 2024. PMID: 37849026 Free PMC article.
-
A protective role for type I interferon signaling following infection with Mycobacterium tuberculosis carrying the rifampicin drug resistance-conferring RpoB mutation H445Y.PLoS Pathog. 2024 Apr 11;20(4):e1012137. doi: 10.1371/journal.ppat.1012137. eCollection 2024 Apr. PLoS Pathog. 2024. PMID: 38603763 Free PMC article.
-
Vaccinia Virus Protein B18R: Influence on mRNA Immunogenicity and Translation upon Non-Viral Delivery in Different Ocular Cell Types.Pharmaceutics. 2021 Jan 7;13(1):74. doi: 10.3390/pharmaceutics13010074. Pharmaceutics. 2021. PMID: 33430462 Free PMC article.
References
-
- Nagano Y, Kojima Y. Immunizing property of vaccinia virus inactivated by ultraviolets rays. C R Seances Soc Biol Fil. 1954;148:1700–1702. - PubMed
-
- Pestka S, Krause CD, Walter MR. Interferons, interferon-like cytokines, and their receptors. Immunol Rev. 2004;202:8–32. - PubMed
-
- Colonna M, Trinchieri G, Liu YJ. Plasmacytoid dendritic cells in immunity. Nat Immunol. 2004;5:1219–1226. - PubMed
-
- Gilliet M, Cao W, Liu YJ. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol. 2008;8:594–606. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources